Winton Group LTD Adma Biologics, Inc. Transaction History
Winton Group LTD
- $1.35 Billion
- Q4 2024
A detailed history of Winton Group LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Winton Group LTD holds 63,909 shares of ADMA stock, worth $991,867. This represents 0.08% of its overall portfolio holdings.
Number of Shares
63,909
Previous 54,336
17.62%
Holding current value
$991,867
Previous $1.09 Million
0.92%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$289 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$282 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$231 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$175 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$85.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.05B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...